アミロイドーシス(Amyloidosis):グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Amyloidosis Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Amyloidosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Amyloidosis to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Amyloidosis to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Amyloidosis 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Amyloidosis Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Amyloidosis 33
Jan 09, 2014: BELLUS Health provides update on KIACTA Phase III orphan drug study 33
Dec 24, 2013: Widely-used anti-inflammatory drug shows success in treatment of amyloidosis 33
Dec 16, 2013: Alnylam Initiates Phase II Clinical Trial with ALN-TTRsc, a Subcutaneously Delivered RNAi Therapeutic Targeting Transthyretin in Development for the Treatment of TTR-Mediated Amyloidosis 34
Nov 10, 2013: Alnylam Reports Positive Phase II Data for Patisiran, an RNAi Therapeutic Targeting Transthyretin for the Treatment of TTR-Mediated Amyloidosis, and Initiates Phase III Trial 35
Sep 30, 2013: Alnylam Completes Enrollment of Phase II Clinical Trial and Initiates Open-Label Extension (OLE) Study with ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin for the Treatment of Transthyretin-Mediated Amyloidos 37
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
Alnylam Pharmaceuticals, Inc. 40
Clinical Trial Overview of Alnylam Pharmaceuticals, Inc. 40
Celgene Corporation 41
Clinical Trial Overview of Celgene Corporation 41
GlaxoSmithKline plc 42
Clinical Trial Overview of GlaxoSmithKline plc 42
Takeda Pharmaceutical Company Limited 43
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 43
Isis Pharmaceuticals, Inc. 44
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 44
Prothena Corporation plc 45
Clinical Trial Overview of Prothena Corporation plc 45
Bellus Health Inc. 46
Clinical Trial Overview of Bellus Health Inc. 46
C.T. Development America, Inc. 47
Clinical Trial Overview of C.T. Development America, Inc. 47
Clinical Trial Overview of Top Institutes / Government 48
Boston Medical Center 48
Clinical Trial Overview of Boston Medical Center 48
Mayo Clinic 49
Clinical Trial Overview of Mayo Clinic 49
National Cancer Institute 50
Clinical Trial Overview of National Cancer Institute 50
Stanford University 51
Clinical Trial Overview of Stanford University 51
Boston University 52
Clinical Trial Overview of Boston University 52
IRCCS Policlinico San Matteo 53
Clinical Trial Overview of IRCCS Policlinico San Matteo 53
IRCCS Policlinico S. Donato 54
Clinical Trial Overview of IRCCS Policlinico S. Donato 54
Memorial Sloan Kettering Cancer Center 55
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 55
Umea University 56
Clinical Trial Overview of Umea University 56
Southwest Oncology Group 57
Clinical Trial Overview of Southwest Oncology Group 57
Five Key Clinical Profiles 58
Appendix 108
Abbreviations 108
Definitions 108
Research Methodology 109
Secondary Research 109
About GlobalData 110
Contact Us 110
Disclaimer 110
Source 110


【レポート販売概要】

■ タイトル:アミロイドーシス(Amyloidosis):グローバル臨床試験レビュー(2014年上半期)
■ 英文:Amyloidosis Global Clinical Trials Review, H1, 2014
■ 発行日:2014年5月5日
■ 調査会社:GlobalData
■ 商品コード:GDHC2131CTIDB
■ 調査対象地域:グローバル
  • 骨粗鬆症:世界市場(医薬品市場予測及び分析~2022)
    PharmaPoint: Osteoporosis - Global Drug Forecast and Market Analysis to 2022 Summary Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and 2022. Most importantly, the ‘gold-standard’ bisphosphonates will lose patent protection by end-of-year 2013, flooding the marketplace with less expensive generic versions of these physician-preferred medication …
  • 民間航空機用着陸装置の世界市場2015-2019
    About Commercial Aircraft Landing Gear Landing gears are one of the most important subsystems installed on an aircraft. They support the entire weight of an aircraft during takeoff and landing, and also during ground operations. The commercial aircraft landing gears are highly advanced and sophisticated systems, and comprise modern control and steering mechanisms. Landing gears also consist of sho …
  • ピザの世界市場2016-2020
    About Pizza Over the years, people worldwide have developed a special craving for pizza, both at home as well as at restaurants. Pizza is the amalgamation of varied parts: crust, vegetables, cheese, sauce, meat or other proteins, and the baking style. All these are vital, but the toppings are the most indispensable ingredient that provides an opportunity to pizza manufacturers to introduce new and …
  • 歯科インプラントの世界市場:チタンインプラント、ジルコニアインプラント
    About Dental Implant A dental implant refers to the replacement of tooth roots and has a high supportive interface between the jaw (skull) and bone. Dental implants help restore the missing teeth or tooth and consist of three major parts: the implant device itself, the abutment, and the crown or denture. A dental implant is made up of biocompatible metal, titanium, and zirconium that offer durabil …
  • レジャーボートの世界市場:新しいレジャーボート別(電動、非電動)、中古レジャーボート別(電動、非電動)、設備別(IoTセンサー、監視機器、テレマティクスソリューション)、地域別予測
    Global Leisure Boat Market to reach USD 54.51 billion by 2025. Global Leisure Boat Market valued approximately USD 35.90 billion in 2016 is anticipated to grow with a healthy growth rate of more than 4.75% over the forecast period 2018-2025. The major factors expected to augment the market are fluctuating economic situations, a rise in consumer disposable income across the world and booming touris …
  • Enteric Diseases in the US 2014: Market Outlook and Emerging Opportunities
    About This ReportThis new 322-page report from Venture Planning Group presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia.  The report provides test volume and sales projections for Hospitals, Physician Offices, Comm …
  • ヒトアルブミンの世界市場2016-2020
    About the Human Albumin Market Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period. T …
  • 手術用スネアの世界市場予測(~2023年)
    “Increasing awareness on colorectal cancer is expected to drive the overall growth of the surgical snares market.”The surgical snares market size is expected to grow from USD 992 million in 2018 to USD 1255 million by 2023, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period. The surgical snares market is driven by various factors such as the increasing number of colon polyp …
  • 世界のハイブリッドクラウド市場
    In todays business environment, organizations strive to meet the constantly changing global business dynamics. Most of the organizations view IT as a tool to be agile and to have a sustainable business success. At the same time, rising IT costs have become a major concern and cost cutting is the current business objective of corporations. Public cloud services have revolutionized the IT industry a …
  • 3Dバイオプリンティングの世界市場2015-2022
    According to Stratistics MRC, the 3D bioprinting market is projected to reach $6,120 million by 2022 growing at a CAGR of 17.4% from 2015 to 2022. Incorporation of IT within the healthcare industry is the key driving factor for the growth of 3D bioprinting market. Rapidly increasing aging population, rising incidence of chronic illnesses, huge investment in R & D, growing demand for organ and tiss …
  • 自動車HUD(ヘッドアップディスプレイ)の世界市場予測(~2025年):コンバイナー、フロントガラス
    “Increasing consumer demand for advanced automotive safety functions and favorable government regulations supporting vehicle safety are expected to fuel the demand for the automotive head-up display (HUD) system”The automotive HUD market is estimated to be USD 759.6 million in 2017 and is projected to grow at a CAGR of 28.54% during the forecast period (2020–2025) to reach a market size of USD 13, …
  • シャーガス心筋症:治療薬の治験動向(2014年下半期)
    Chagas Cardiomyopathy Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Chagas Cardiomyopathy Global Clinical Trials Review, H2, 2014" provides data on the Chagas Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chagas Cardiomyopathy. It includes an overview of the trial numbers and the …
  • スペアパーツロジスティクスの世界市場2019-2023
    About this market The high population density acts as a major driver for trade between India and China. In 2017. India increased the import duty on certain product categories (such as mobile phones. watches, and perfumes) imported from China. However. the increase in import duty will take a long time to have a serious impact on China's imports to India. The growing trade of HS Code 85 products bet …
  • 世界のポリオキシメチレン(ポリアセタール)市場動向(~2018)
    Polyoxymethylene (POM) is an engineering plastic which finds its applications in many end-user industries. Properties such as excellent dimensional stability, high strength, and good resistance to impact & fatigue make polyoxymethylene a preferred material in the category of high performance engineering plastics. Polyoxymethylene is generally used because of its excellent physical properties which …
  • フィルターの世界市場分析:製品別(流体、ICエンジン、空気)、用途別(自動車、消費者用、公益事業、産業用・製造業)、セグメント予測、-2020
    The Global Filters Market is expected to reach USD 88.19 billion by 2020, according to a new study by Grand View Research, Inc. Growing consumer awareness on account of rising environmental concerns is expected to remain a key driving factor for the global market. In addition, favorable regulatory scenario coupled with increasing demand for automobile and consumer goods is also expected to have a …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。